drugset / Trial / NCT00118495

Zestra in Women With Mixed Sexual Dysfunction

NCT00118495 ↗

Phase 3 Completed 200 enrolled QualiLife Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is to evaluate the clinical efficacy and safety of Zestra(TM) in women with acquired mixed desire/interest/arousal/orgasm disorders under conditions of home usage. The primary efficacy hypothesis will compare the effect of Zestra versus placebo on the incidence of "successful and satisfactory" sexual encounters.

Timeline

Start
2006-03
Primary completion
—
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Zestra(TM) Unknown — —

Indications